Developer docs
API playgroundTry for free, no card

Search company profiles

Handok

Full company profile

uuid0009dm3

Namestring
Handok
Legal namestring
주식회사 한독
Websiteurl
handok.co.kr
Company typeenum
Public
Founded yearint
1954
Descriptiontext

Handok (주식회사 한독) is a Seoul-headquartered Korean pharmaceutical company founded in 1954, operating as a publicly structured stock company with 501–1,000 employees across a 13-location national network including Gangnam headquarters, a Magok R&D complex, an Eumseong manufacturing facility, and regional branch offices. The company self-describes as a "Total Healthcare Company" spanning prescription pharmaceuticals, over-the-counter medicines, medical devices, in vitro diagnostics, research-use products, digital healthcare, and health functional foods.

Its core product franchise is anchored by two decades-long #1 consumer brands: Ketotop (ketoprofen-based topical anti-inflammatory patches, #1 in Korean external analgesics for 26+ consecutive years per IQVIA) and Festal (digestive enzymes first launched in 1958 and #1 in the A09A OTC digestive-enzyme segment for over 20 years per IQVIA). The medical-device line centers on the Barozen brand — blood glucose meters and test strips, the new Barozen Fit continuous glucose monitor, automatic blood pressure monitors (Pulse/Pulse Plus), and consumables (lancets, alcohol swabs, insulin pen needles). Adjacent OTC and functional-food brands include FESS hypertonic nasal spray, Clearteen acne treatments, ItchyRescue bug-bite patches, Theracurmin curcumin supplements, Natureset functional foods, and the Ready Q hangover-relief line.

Handok generates revenue through a sales-led, multi-channel model: pharmacies and hospitals for prescription and OTC drugs, convenience stores for smaller-pack OTC SKUs (e.g., 6-tab Festal packs), direct sales into medical institutions for devices and ethical drugs, and the everydayhealth.co.kr e-commerce portal for direct-to-consumer health products. Pricing is not publicly disclosed; revenue streams are characterized as one-time product sales across pharmaceuticals, hardware sales for medical devices, and direct e-commerce. The company also runs clinical and adverse-event data-sharing arrangements with multinational pharma partners (Roche, Novartis, Pfizer, Sanofi, Bayer, Abbott, Astellas, Lilly, Eisai, GSK) for regulatory compliance.

Short descriptiontext

Handok is a 70-year-old Korean pharmaceutical company that develops, manufactures, and distributes prescription drugs, OTC consumer health brands (Ketotop, Festal), Barozen medical devices including a continuous glucose monitor, digital healthcare services, and health functional foods across pharmacy, hospital, convenience-store, and e-commerce channels in South Korea.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersSeoul, South Korea
HQ citystring
Seoul
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices13 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, OTC medicines, medical devices, health functional foods, prescription drugs
Industry4 codes
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRADAMAC
OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAIADAA
Pain Relief & Anti-Inflammatory (Analgesics)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYCRADAMAF
Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
NAICS code2 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Products
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Pharmaceutical Products
TypeOne Time License
Description

Revenue from prescription drugs (전문의약품), over-the-counter medicines (일반의약품), and health functional foods. Key brands include Ketotop, Festal, and various prescription medications.

handok.co.kr
2Medical Devices
TypeHardware Sales
Description

Revenue from medical devices including Barozen blood glucose monitors, blood pressure monitors, and nasal sprays (FESS).

handok.co.kr
3Health Functional Foods
TypeOne Time License
Description

Revenue from health supplements sold through everydayhealth.co.kr e-commerce platform.

handok.co.kr
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1케토톱 (Ketotop)
Description

Top-selling topical anti-inflammatory analgesic patch brand for arthritis treatment, maintaining No. 1 position for 26+ years

handok.co.kr
+7 more records
Core offering1 text field

Handok manufactures and distributes a broad healthcare portfolio spanning prescription pharmaceuticals, over-the-counter (OTC) medicines, medical devices (notably the Barozen blood glucose and blood pressure monitors), and health functional foods and cosmetics. Flagship consumer brands include Ketotop topical anti-inflammatory patches (Korea's #1 topical analgesic for 26+ years per IQVIA), Festal digestive enzyme supplements (Korea's first tablet digestive aid since 1958 and #1 in digestive enzymes), FESS nasal sprays, Clearteen acne treatments, Theracurmin curcumin supplements, Natureset health functional foods, and Ready Q hangover relief products.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Ketotop maintains #1 position in topical anti-inflammatory analgesics for 26+ years (IQVIA 1996 4Q MAT - 2024 4Q MAT)
+1 more record
Product overview1 text field

Handok is a Total Healthcare Company offering a broad portfolio spanning prescription pharmaceuticals (전문의약품), general pharmaceuticals (일반의약품), medical devices, in vitro diagnostic devices, research-use products, digital healthcare, and health functional foods. Its flagship general pharma brands include the anti-inflammatory patch KETOTOP (26-year market leader), the digestive supplement FESTAL (Korea's first tablet digestive aid since 1958, No.1 in digestive enzyme market), the nasal spray FESS Natural (Korea's only hypertonic nasal spray for daily use), the acne treatment CLEARTEEN, and the bug-bite relief patch ITCHYRESCUE. The medical device portfolio centers on the BAROZEN brand for blood glucose and blood pressure management, including the BAROZEN Fit continuous glucose monitoring system (CGM). Handok also markets health functional foods and general foods under brands including TERACURMIN (enhanced-bioavailability curcumin), NATURESET, and READY Q (hangover relief), sold through its consumer portal everydayhealth.co.kr. The company operates prescription drug, in vitro diagnostic, research product, and digital health divisions alongside its core OTC and medical device lines.

Product and service1 record
1Ketotop (케토톱)
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Roche partnership involves digital media marketing activities including pharmaceutical information delivery, event coordination, content distribution, and market research management. Handok handles adverse event data sharing and clinical trial information with Roche for regulatory compliance and product registration purposes.

2Abbott Korea
Strategic tierMinorTypeOthers
Description

Listed as international partner company in Handok's privacy policy for adverse event reporting and clinical trial data exchange purposes.

handok.co.kr
Strategic tierMinorTypeOthers
Description

Listed as international partner company for adverse event reporting and clinical trial data exchange.

Strategic tierMinorTypeOthers
Description

Listed as international partner company for adverse event reporting and clinical trial data exchange.

Strategic tierMinorTypeOthers
Description

Listed as international partner company for adverse event reporting and clinical trial data exchange.

6Novartis Korea
Strategic tierMinorTypeOthers
Description

Listed as international partner company for adverse event reporting and clinical trial data exchange.

handok.co.kr
Strategic tierMinorTypeOthers
Description

Listed as international partner company for adverse event reporting and clinical trial data exchange.

Strategic tierMinorTypeOthers
Description

Listed as international partner company for adverse event reporting and clinical trial data exchange.

Strategic tierMinorTypeOthers
Description

Listed as international partner company for adverse event reporting and clinical trial data exchange.

Strategic tierMinorTypeOthers
Description

Listed as international partner company for adverse event reporting and clinical trial data exchange.

Strategic tierCoreTypeTechnology or Integration
Description

Veeva provides CRM cloud services (Veeva CRM) for sales force automation and customer relationship management. Handok uses Veeva for contract management, customer data handling, and cloud-based service operation. Data stored on Salesforce.com and AWS infrastructure.

Strategic tierCoreTypeTechnology or Integration
Description

Microsoft provides Microsoft 365 Copilot AI services for business workflow support and productivity enhancement.

Strategic tierCoreTypeTechnology or Integration
Description

AWS cloud infrastructure used by Veeva for real-time CRM data storage and service operation. Handok data stored through Veeva's cloud services.

Strategic tierCoreTypeTechnology or Integration
Description

Salesforce.com provides cloud infrastructure for Veeva CRM services used by Handok for customer relationship management.

Strategic tierMinorTypeOthers
Description

Handok is a member of the association and reports quarterly on compliance with fair competition rules regarding speaker fees and consulting payments to healthcare professionals.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the largest Korean pharmaceutical companies, founded 1926, with a similar mix of prescription drugs, OTC consumer health brands, and established distribution across Korean pharmacies and hospitals. Closely comparable as a diversified Korean pharma peer of similar vintage.

2Dong-A ST (Dong-A Pharmaceutical)
TypeDirect peer
Description

Major Korean pharmaceutical manufacturer with leading consumer healthcare brands (e.g., Bacchus energy drink) and a prescription drug portfolio. Comparable to Handok across the prescription/OTC/consumer health split and Korean market focus.

TypeDirect peer
Description

Established Korean biopharmaceutical company with prescription biologics, vaccines, and OTC products. Comparable as a domestic pharma peer with both innovative biologics pipeline and consumer health products distributed through Korean channels.

Description

Innovation-focused Korean pharma with a strong specialty drug pipeline and out-licensing model. Relevant peer given Handok's open-innovation R&D approach (e.g., Resolution subsidiary for ersodutug) and competing for the same HCP audience in Korea.

TypeDirect peer
Description

Korean pharmaceutical company with both prescription drugs (e.g., botulinum toxin Nabota) and a consumer healthcare portfolio. Comparable to Handok across Rx/OTC mix and nationwide pharmacy distribution.

6Chong Kun Dang Pharmaceutical
TypeDirect peer
Description

Mid-to-large Korean pharmaceutical manufacturer with prescription and OTC products including established consumer brands. Comparable as a domestic pharma peer competing for similar HCP and pharmacy shelf space.

TypeDirect peer
Description

Korean pharma with both prescription drugs (notably antihypertensives) and a strong OTC consumer health portfolio (e.g., Kanarb). Comparable to Handok's prescription-plus-OTC structure and Korean distribution model.

TypeDirect peer
Description

Long-established Korean pharmaceutical company with prescription and OTC/herbal medicine portfolio. Comparable as a domestic peer with similar vintage and Hanpoong-style OTC heritage.

TypeBroad incumbent
Description

Global pharmaceutical major and Handok's Core strategic partner for digital media, clinical trial coordination, and adverse-event reporting. Comparable as a multinational incumbent whose innovative Rx portfolio is commercialized in part through Handok's Korean infrastructure.

10Abbott Korea
TypeBroad incumbent
Description

Global healthcare company with diagnostics, medical devices (including FreeStyle Libre CGM that competes with Barozen Fit), and consumer health lines. Comparable as a multinational incumbent whose CGM and diabetes device portfolio directly overlaps with Handok's Barozen medical device business.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment6 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Handok

Pharmaceutical Productshandok.co.kr

Handok is a 70-year-old Korean pharmaceutical company that develops, manufactures, and distributes prescription drugs, OTC consumer health brands (Ketotop, Festal), Barozen medical devices including a continuous glucose monitor, digital healthcare services, and health functional foods across pharmacy, hospital, convenience-store, and e-commerce channels in South Korea.

What Handok does

Handok (주식회사 한독) is a Seoul-headquartered Korean pharmaceutical company founded in 1954, operating as a publicly structured stock company with 501–1,000 employees across a 13-location national network including Gangnam headquarters, a Magok R&D complex, an Eumseong manufacturing facility, and regional branch offices. The company self-describes as a "Total Healthcare Company" spanning prescription pharmaceuticals, over-the-counter medicines, medical devices, in vitro diagnostics, research-use products, digital healthcare, and health functional foods.

Its core product franchise is anchored by two decades-long #1 consumer brands: Ketotop (ketoprofen-based topical anti-inflammatory patches, #1 in Korean external analgesics for 26+ consecutive years per IQVIA) and Festal (digestive enzymes first launched in 1958 and #1 in the A09A OTC digestive-enzyme segment for over 20 years per IQVIA). The medical-device line centers on the Barozen brand — blood glucose meters and test strips, the new Barozen Fit continuous glucose monitor, automatic blood pressure monitors (Pulse/Pulse Plus), and consumables (lancets, alcohol swabs, insulin pen needles). Adjacent OTC and functional-food brands include FESS hypertonic nasal spray, Clearteen acne treatments, ItchyRescue bug-bite patches, Theracurmin curcumin supplements, Natureset functional foods, and the Ready Q hangover-relief line.

Handok generates revenue through a sales-led, multi-channel model: pharmacies and hospitals for prescription and OTC drugs, convenience stores for smaller-pack OTC SKUs (e.g., 6-tab Festal packs), direct sales into medical institutions for devices and ethical drugs, and the everydayhealth.co.kr e-commerce portal for direct-to-consumer health products. Pricing is not publicly disclosed; revenue streams are characterized as one-time product sales across pharmaceuticals, hardware sales for medical devices, and direct e-commerce. The company also runs clinical and adverse-event data-sharing arrangements with multinational pharma partners (Roche, Novartis, Pfizer, Sanofi, Bayer, Abbott, Astellas, Lilly, Eisai, GSK) for regulatory compliance.

Handok firmographics

Firmographics
Name
Handok
Legal name
주식회사 한독
Website
https://handok.co.kr
Company type
Public
Founded year
1954
Operating status
Operating
Headcount range
251–500 employees
Short description
Handok is a 70-year-old Korean pharmaceutical company that develops, manufactures, and distributes prescription drugs, OTC consumer health brands (Ketotop, Festal), Barozen medical devices including a continuous glucose monitor, digital healthcare services, and health functional foods across pharmacy, hospital, convenience-store, and e-commerce channels in South Korea.
Ownership category
akta.pro rank

Handok industry classification

Industry
Product category
Pharmaceutical Products
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRADAMAC
OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAIADAA
Pain Relief & Anti-Inflammatory (Analgesics)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYCRADAMAF
Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)

Keywords

  • Pharmaceutical manufacturing
  • OTC medicines
  • Medical devices
  • Health functional foods
  • Prescription drugs

Where Handok is headquartered

Location

Headquarters

HQ city
Seoul
HQ country
South Korea
HQ region
Asia

Offices13 records

Markets served

Handok business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Pharmaceutical Products: Revenue from prescription drugs (전문의약품), over-the-counter medicines (일반의약품), and health functional foods. Key brands include Ketotop, Festal, and various prescription medications.
  2. Medical Devices: Revenue from medical devices including Barozen blood glucose monitors, blood pressure monitors, and nasal sprays (FESS).
  3. Health Functional Foods: Revenue from health supplements sold through everydayhealth.co.kr e-commerce platform.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Handok product offering

Product offering

Core offering

Handok manufactures and distributes a broad healthcare portfolio spanning prescription pharmaceuticals, over-the-counter (OTC) medicines, medical devices (notably the Barozen blood glucose and blood pressure monitors), and health functional foods and cosmetics. Flagship consumer brands include Ketotop topical anti-inflammatory patches (Korea's #1 topical analgesic for 26+ years per IQVIA), Festal digestive enzyme supplements (Korea's first tablet digestive aid since 1958 and #1 in digestive enzymes), FESS nasal sprays, Clearteen acne treatments, Theracurmin curcumin supplements, Natureset health functional foods, and Ready Q hangover relief products.

Product overview

Handok is a Total Healthcare Company offering a broad portfolio spanning prescription pharmaceuticals (전문의약품), general pharmaceuticals (일반의약품), medical devices, in vitro diagnostic devices, research-use products, digital healthcare, and health functional foods. Its flagship general pharma brands include the anti-inflammatory patch KETOTOP (26-year market leader), the digestive supplement FESTAL (Korea's first tablet digestive aid since 1958, No.1 in digestive enzyme market), the nasal spray FESS Natural (Korea's only hypertonic nasal spray for daily use), the acne treatment CLEARTEEN, and the bug-bite relief patch ITCHYRESCUE. The medical device portfolio centers on the BAROZEN brand for blood glucose and blood pressure management, including the BAROZEN Fit continuous glucose monitoring system (CGM). Handok also markets health functional foods and general foods under brands including TERACURMIN (enhanced-bioavailability curcumin), NATURESET, and READY Q (hangover relief), sold through its consumer portal everydayhealth.co.kr. The company operates prescription drug, in vitro diagnostic, research product, and digital health divisions alongside its core OTC and medical device lines.

Differentiator

Problem solved

Functional benefit

Brands

  • 케토톱 (Ketotop): Top-selling topical anti-inflammatory analgesic patch brand for arthritis treatment, maintaining No. 1 position for 26+ years
  • 훼스탈 (Festal)
  • 바로잰 (Barozen)
  • 네이처셋 (Natureset)
  • 테라큐민 (Theracurmin)
  • 클리어틴 (Clearteen)
  • 페스 (FESS)
  • 이치레스큐 (ItchyRescue)

Products and services

  • Ketotop (케토톱)

Quantifiable outcome

  • Ketotop maintains #1 position in topical anti-inflammatory analgesics for 26+ years (IQVIA 1996 4Q MAT - 2024 4Q MAT)
  • +1 more outcomes

Companies that use Handok

Customer profile

Named customers1 record

Segments5 records

Ideal customer profiles5 records

Handok technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Handok partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered core and minor.

  • F. Hoffmann-La Roche AG / Roche KoreacoreStrategic or Co-development PartnerRoche partnership involves digital media marketing activities including pharmaceutical information delivery, event coordination, content distribution, and market research management. Handok handles adverse event data sharing and clinical trial information with Roche for regulatory compliance and product registration purposes.
  • Abbott KoreaminorOthersListed as international partner company in Handok's privacy policy for adverse event reporting and clinical trial data exchange purposes.
  • Astellas KoreaminorOthersListed as international partner company for adverse event reporting and clinical trial data exchange.
  • Bayer KoreaminorOthersListed as international partner company for adverse event reporting and clinical trial data exchange.
  • Pfizer KoreaminorOthersListed as international partner company for adverse event reporting and clinical trial data exchange.
  • Novartis KoreaminorOthersListed as international partner company for adverse event reporting and clinical trial data exchange.
  • Sanofi KoreaminorOthersListed as international partner company for adverse event reporting and clinical trial data exchange.
  • GSK KoreaminorOthersListed as international partner company for adverse event reporting and clinical trial data exchange.
  • Lilly KoreaminorOthersListed as international partner company for adverse event reporting and clinical trial data exchange.
  • Eisai KoreaminorOthersListed as international partner company for adverse event reporting and clinical trial data exchange.
  • Veeva SystemscoreTechnology or IntegrationVeeva provides CRM cloud services (Veeva CRM) for sales force automation and customer relationship management. Handok uses Veeva for contract management, customer data handling, and cloud-based service operation. Data stored on Salesforce.com and AWS infrastructure.
  • Microsoft CorporationcoreTechnology or IntegrationMicrosoft provides Microsoft 365 Copilot AI services for business workflow support and productivity enhancement.
  • AWS (Amazon Web Services)coreTechnology or IntegrationAWS cloud infrastructure used by Veeva for real-time CRM data storage and service operation. Handok data stored through Veeva's cloud services.
  • Salesforce.comcoreTechnology or IntegrationSalesforce.com provides cloud infrastructure for Veeva CRM services used by Handok for customer relationship management.
  • Korea Pharmaceutical and Bio-Pharma Manufacturers AssociationminorOthersHandok is a member of the association and reports quarterly on compliance with fair competition rules regarding speaker fees and consulting payments to healthcare professionals.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Handok competitors and assessment

Company assessment

Direct peers

  • Yuhan Corporation: One of the largest Korean pharmaceutical companies, founded 1926, with a similar mix of prescription drugs, OTC consumer health brands, and established distribution across Korean pharmacies and hospitals. Closely comparable as a diversified Korean pharma peer of similar vintage.
  • Dong-A ST (Dong-A Pharmaceutical): Major Korean pharmaceutical manufacturer with leading consumer healthcare brands (e.g., Bacchus energy drink) and a prescription drug portfolio. Comparable to Handok across the prescription/OTC/consumer health split and Korean market focus.
  • GC Biopharma (formerly Green Cross Corporation): Established Korean biopharmaceutical company with prescription biologics, vaccines, and OTC products. Comparable as a domestic pharma peer with both innovative biologics pipeline and consumer health products distributed through Korean channels.
  • Daewoong Pharmaceutical: Korean pharmaceutical company with both prescription drugs (e.g., botulinum toxin Nabota) and a consumer healthcare portfolio. Comparable to Handok across Rx/OTC mix and nationwide pharmacy distribution.
  • Chong Kun Dang Pharmaceutical: Mid-to-large Korean pharmaceutical manufacturer with prescription and OTC products including established consumer brands. Comparable as a domestic pharma peer competing for similar HCP and pharmacy shelf space.
  • Boryung Pharmaceutical: Korean pharma with both prescription drugs (notably antihypertensives) and a strong OTC consumer health portfolio (e.g., Kanarb). Comparable to Handok's prescription-plus-OTC structure and Korean distribution model.
  • Dong Wha Pharmaceutical: Long-established Korean pharmaceutical company with prescription and OTC/herbal medicine portfolio. Comparable as a domestic peer with similar vintage and Hanpoong-style OTC heritage.

Peers

  • Hanmi Pharmaceutical: Innovation-focused Korean pharma with a strong specialty drug pipeline and out-licensing model. Relevant peer given Handok's open-innovation R&D approach (e.g., Resolution subsidiary for ersodutug) and competing for the same HCP audience in Korea.

Broad incumbents

  • Roche Korea: Global pharmaceutical major and Handok's Core strategic partner for digital media, clinical trial coordination, and adverse-event reporting. Comparable as a multinational incumbent whose innovative Rx portfolio is commercialized in part through Handok's Korean infrastructure.
  • Abbott Korea: Global healthcare company with diagnostics, medical devices (including FreeStyle Libre CGM that competes with Barozen Fit), and consumer health lines. Comparable as a multinational incumbent whose CGM and diabetes device portfolio directly overlaps with Handok's Barozen medical device business.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Handok social profiles

Digital presence

Handok financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Handok leadership team

Management profile

Number of profiles

Profiles4 records

Handok subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Handok funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Handok M&A and investment

M&A and investment

M&A

Investments6 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Handok

What does Handok do?

Handok manufactures and distributes a broad healthcare portfolio spanning prescription pharmaceuticals, over-the-counter (OTC) medicines, medical devices (notably the Barozen blood glucose and blood pressure monitors), and health functional foods and cosmetics. Flagship consumer brands include Ketotop topical anti-inflammatory patches (Korea's #1 topical analgesic for 26+ years per IQVIA), Festal digestive enzyme supplements (Korea's first tablet digestive aid since 1958 and #1 in digestive enzymes), FESS nasal sprays, Clearteen acne treatments, Theracurmin curcumin supplements, Natureset health functional foods, and Ready Q hangover relief products.

Is Handok a public or private company?

Handok is a public company. It is classified as public and is currently operating.

When was Handok founded?

Handok was founded in 1954. It employs 251 to 500 people.

Where is Handok based?

Handok is headquartered in Seoul, South Korea, in the Asia region.

How does Handok make money?

Three revenue lines are on record. Pharmaceutical Products are the primary driver. The others are medical Devices and health Functional Foods.

Who are Handok's main competitors?

Direct peers on record are Yuhan Corporation, Dong-A ST (Dong-A Pharmaceutical), GC Biopharma (formerly Green Cross Corporation), Daewoong Pharmaceutical, Chong Kun Dang Pharmaceutical, Boryung Pharmaceutical and Dong Wha Pharmaceutical. Hanmi Pharmaceutical is listed as a peer. Broad incumbents are Roche Korea and Abbott Korea.

Does Handok have an API?

No public API is recorded for Handok.

What industry is Handok in?

Handok's product category is Pharmaceutical Products. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of CRADAMAC, OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief). Its NAICS code is 3254 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
VenturesquareAutomatically record sleep rhythm for 14 days with a smartphone... A-Sleep and Handok sign distribution contract for 'ChronoTrack'.A-Sleep and Handok signed a distribution agreement for ChronoTrack, a digital medical device that records 14 days of sleep via smartphone and analyzes it with AI. The device calculates total sleep time, efficiency, and regularity, and supports the FZ700 sleep rhythm test. Handok will supply it through its nationwide hospital network.NateAlready 1000 places have adopted it... Hospitals treating insomnia with an 'app': Nate NewsHandok and Welt's digital insomnia treatment device, SleepQ, has surpassed 1,000 cumulative registrations at the Korea Health and Medical Research Institute (NECA), indicating growing adoption of digital treatment devices among medical institutions in Korea. SleepQ is a smartphone application that delivers cognitive behavioral therapy for insomnia and was approved by Korea's Ministry of Food and Drug Safety as the first innovative medical device for integrated review. Clinical trial data showed patients using SleepQ achieved a 15.14% improvement in sleep efficiency and reduced the time to fall asleep from an average of 65.7 minutes to 35.8 minutes over seven weeks.ChosunbizPharmaceutical Firms Target 7.7 Trillion Won Digital Healthcare MarketCheonggu Seongsim Hospital in Seoul has implemented Daewoong Pharmaceutical's AI bed monitoring system "Think" across its 196 general ward beds, enabling real-time biometric monitoring and reducing nursing staff workload. Domestic pharmaceutical companies including Daewoong Pharmaceutical, Dong-A ST, Handok, and Yuhan Corporation are accelerating their digital healthcare investments to diversify revenue amid government pressure to lower generic drug prices, with the global digital healthcare market projected to grow from $187.7 billion in 2025 to $246.7 billion by 2029. Daewoong Pharmaceutical aims to supply its monitoring system to over 100,000 beds and achieve annual sales of 300 billion Korean won in its digital healthcare division.National Center for Biotechnology InformationAdvances in Continuous Glucose Monitoring: Clinical ApplicationsThis review article analyzes the clinical efficacy and features of continuous glucose monitoring (CGM) systems, highlighting their role in improving glycemic control and reducing hypoglycemia across type 1 and type 2 diabetes populations. It details the specifications of major commercial devices from manufacturers including Abbott, Dexcom, Medtronic, i-SENS, and Handok, noting improvements in accuracy and integration with insulin delivery systems.Benzinga$17M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying - BESPThis article highlights recent insider trading activity across four penny stocks listed on NASDAQ and OTC markets. Notable transactions include Heritage Global President Nicholas Kirk Dove acquiring 5,000 shares for approximately $14,400, Bespoke Extracts CEO Michael Feinsod purchasing 5,000 shares for $750, CPS Technologies Director Daniel C Snow buying 2,500 shares for $4,500, and Handok Inc. acquiring 3,927,126 shares of Rezolute for approximately $17 million. The article notes market context from the Dow Jones gaining over 300 points and references recent earnings reports for some of the featured companies.PR NewswireGlobal TRK Inhibitors Market Report 2021: Vitrakvi and Rozlytrek have Gained Approval Bodies - A $2 Billion Opportunity by 2026ResearchAndMarkets.com published a market report on the global TRK inhibitors sector, identifying two approved drugs—Vitrakvi (Larotrectinib) and Rozlytrek (Entrectinib)—for treating NTRK gene fusion-positive cancers, with the market projected to exceed $2 billion by 2026. In May 2021, AUM Biosciences entered into a collaboration with Handok and CMG Pharmaceutical for worldwide development and commercialization rights to the pan-TRK inhibitor CHC2014, reflecting active deal-making in this competitive therapeutic space. Key players in the TRK inhibitor market include AstraZeneca, Pfizer, Bayer, Loxo Oncology, InnoCare, Ono Pharmaceutical, and Turning Point Therapeutics, with next-generation inhibitors like Selitrectinib and Repotrectinib advancing through Phase II clinical trials to address resistance to first-generation drugs.